(Q84932222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

mucopolysaccharidosis I

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Brian Bigger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Kia Langford-Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Malani Arasaradnam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Ed Wraith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

23 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

269-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Bone-Marrow Transplantation in the Maroteaux–Lamy Syndrome (Mucopolysaccharidosis Type VI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Disease-specific markers for the mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Heparin cofactor II–thrombin complex in MPS I: A biomarker of MPS disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.175

10.1016/J.YMGME.2009.10.175

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19926322%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference